ALX-0171 Phase I Pharmacokinetic Study in Healthy Male Volunteers

Clinical trial NCT01875926 · COMPLETED

Trial details

NCT number: NCT01875926
Sponsor: Ablynx, a Sanofi company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy RSV Infection

Start date: 2013-05-01
Primary completion: 2013-10-01
Enrollment: 44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.